FDA Publishes Small Entity Guide For Supplement GMPs
FDA publishes good manufacturing practices guidance for small businesses making dietary supplements nearly six months after the deadline for compliance with the GMP final rule.
More from Archive
More from Pink Sheet
• By
ISRCTN’s systems are being redesigned to facilitate compliance with upcoming requirements in the UK’s clinical trials legislation.
• By
The use of J&J’s Darzalex Faspro in high-risk smoldering multiple myeloma could result in overtreatment, but the FDA committee voted in favor of the new claim for delay in development of multiple myeloma.
• By
The glofitamab trial results are not generalizable due to the small number of enrolled US lymphoma patients and adverse results across multiple endpoints for patients from non-Asian regions, the Oncologic Drugs Advisory Committee said.